CE Credit: 1 CM
Amyotrophic lateral sclerosis, also known as ALS or "Lou Gehrig's Disease," is a disorder of motor nerves that affects 1 out 100,000 people. This is a rare but dreaded disease, producing total paralysis and, ultimately, death in all patients (on average, only after 3 or 4 years). This talk will review current management strategies for patients with ALS as well research looking to slow disease progression.
Speaker Bio
Dr. Saperstein is co-director of the Banner Good Samaritan ALS Clinic. He is a graduate of Boston University School of Medicine. Dr. Saperstein performed a Neurology residency at Wilford Hall USAF Medical Center in San Antonio, TX, followed by a Neuromuscular Disease/Clinical Neurophysiology fellowship at the University of Texas Southwestern Medical Center in Dallas. He is board certified in Neurology, Neuromuscular Medicine and Electrodiagnostic Medicine. He has participated in multicenter research studies of treatments for amyotrophic lateral sclerosis, myasthenia gravis, immune-mediated neuropathies, and muscular dystrophy. Dr. Saperstein has authored or co-authored over 40 journal articles, book chapters, and abstracts regarding various aspects of nerve and muscle disease.